First Manhattan CO Enanta Pharmaceuticals Inc Transaction History

First Manhattan CO

$31.9 Billion
Q3 2024

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	BUY	$38.82 - $54.59 $763,084 - $1.07 Million	19,657 Added 8.07%	263,375 $10.7 Million
Q3 2022 Nov 14, 2022	BUY	$48.29 - $71.27 $768,342 - $1.13 Million	15,911 Added 6.98%	243,718 $12.6 Million
Q2 2022 Aug 15, 2022	SELL	$38.13 - $76.93 $21.4 Million - $43.2 Million	-561,504 Reduced 71.14%	227,807 $10.8 Million
Q1 2022 May 16, 2022	SELL	$56.06 - $74.11 $10.1 Million - $13.4 Million	-180,425 Reduced 18.61%	789,311 $56.2 Million
Q3 2021 Nov 15, 2021	BUY	$41.02 - $58.65 $38.4 Million - $54.9 Million	936,536 Added 2820.89%	969,736 $55.1 Million
Q2 2021 Aug 16, 2021	BUY	$43.76 - $53.11 $1.45 Million - $1.76 Million	33,200 New	33,200 $1.46 Million
Q1 2021 May 14, 2021	SELL	$41.69 - $54.95 $9.91 Million - $13.1 Million	-237,679 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$41.16 - $47.47 $5.65 Million - $6.51 Million	-137,206 Reduced 36.6%	237,679 $10 Million
Q3 2020 Nov 12, 2020	SELL	$43.36 - $53.53 $837,368 - $1.03 Million	-19,312 Reduced 4.9%	374,885 $17.2 Million
Q2 2020 Aug 14, 2020	SELL	$46.37 - $57.58 $834,660 - $1.04 Million	-18,000 Reduced 4.37%	394,197 $19.8 Million
Q1 2020 May 06, 2020	SELL	$40.22 - $62.0 $5.39 Million - $8.32 Million	-134,134 Reduced 24.55%	412,197 $21.2 Million
Q4 2019 Feb 13, 2020	BUY	$57.95 - $66.61 $2.18 Million - $2.51 Million	37,701 Added 7.41%	546,331 $33.8 Million
Q3 2019 Nov 13, 2019	SELL	$60.08 - $88.17 $6.56 Million - $9.62 Million	-109,141 Reduced 17.67%	508,630 $30.6 Million
Q2 2019 Aug 16, 2019	SELL	$81.3 - $97.35 $3.83 Million - $4.59 Million	-47,163 Reduced 7.09%	617,771 $52.1 Million
Q1 2019 Apr 12, 2019	SELL	$69.08 - $105.66 $1.02 Million - $1.56 Million	-14,800 Reduced 2.18%	664,934 $63.5 Million
Q4 2018 Jan 30, 2019	SELL	$65.41 - $84.65 $1.22 Million - $1.58 Million	-18,700 Reduced 2.68%	679,734 $48.1 Million
Q3 2018 Oct 15, 2018	BUY	$85.46 - $126.37 $11 Million - $16.3 Million	129,026 Added 22.66%	698,434 $59.7 Million
Q2 2018 Aug 01, 2018	SELL	$81.85 - $120.51 $24.7 Million - $36.4 Million	-302,367 Reduced 34.68%	569,408 $66 Million
Q1 2018 Apr 20, 2018	SELL	$57.91 - $92.15 $12.3 Million - $19.6 Million	-212,425 Reduced 19.59%	871,775 $70.5 Million
Q4 2017 Jan 22, 2018	BUY	$45.65 - $59.37 $6.26 Million - $8.14 Million	137,100 Added 14.48%	1,084,200 $63.6 Million
Q3 2017 Oct 25, 2017	BUY	$37.91 - $46.8 $35.9 Million - $44.3 Million	947,100	947,100 $44.3 Million

Others Institutions Holding ENTA

# of Institutions

109

Shares Held

21.2M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$10.9 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$10.2 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$9.55 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$7.75 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$5.7 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $107M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of First Manhattan CO, based on Form 13F filings with the SEC.

News

Stay updated on First Manhattan CO with notifications on news.

Account